Literature DB >> 17614008

Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates.

K-I Umehara1, T Iwatsubo, K Noguchi, H Kamimura.   

Abstract

In this study, the comparison of the transport of substrates (1-methyl-4-phenylpydinium (MPP) and tetraethyl ammonium (TEA)) and the inhibition potency of the inhibitors (biguanides and H(2)-blockers) for human and rat organic cation transporters (hOCTs and rOcts), and the inhibition type of inhibitors for these transporters were investigated using HEK293 cells that stably express hOCT/rOct. The concentration-dependent uptake of [(3)H]-MPP and [(14)C]-TEA by hOCT1-3/rOct1-3 had K(m) values similar to those in the literature. It was also deduced that MPP and TEA are competitive inhibitors for hOCT1-2/rOct1-2. The K(i) values for phenformin inhibition of [(3)H]-MPP and [(14)C]-TEA uptake by hOCT1-3/rOct1-3 were lower than that for metformin. The [(3)H]-MPP uptake by hOCT1/rOct1 and hOCT3/rOct3 was inhibited by famotidine and ranitidine whereas that by hOCT2/rOct2 was not. The inhibitory potency of cimetidine for hOCT1-2 was very weak. In most cases, the differences in the V(max)/K(m) values of substrates and the K(i) values of inhibitors between hOCT and rOct were minor. The acquisition of information on OCT/Oct mediated-transport and/or inhibition such as that presented in this report is very useful for further understanding of certain aspects of uptake, distribution, and excretion for drug candidates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17614008     DOI: 10.1080/00498250701397705

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  11 in total

1.  Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake.

Authors:  Kelli H Boxberger; Bruno Hagenbuch; Jed N Lampe
Journal:  Drug Metab Dispos       Date:  2014-03-31       Impact factor: 3.922

2.  Immunohistochemical and functional characterization of peptide, organic cation, neutral and basic amino acid, and monocarboxylate drug transporters in human ocular tissues.

Authors:  Rajendra S Kadam; Sunil K Vooturi; Uday B Kompella
Journal:  Drug Metab Dispos       Date:  2012-11-20       Impact factor: 3.922

Review 3.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

4.  Unstirred Water Layers and the Kinetics of Organic Cation Transport.

Authors:  Takahiro Shibayama; Mark Morales; Xiaohong Zhang; Lucy J Martínez-Guerrero; Alfred Berteloot; Timothy W Secomb; Stephen H Wright
Journal:  Pharm Res       Date:  2015-03-20       Impact factor: 4.200

5.  Novel method for kinetic analysis applied to transport by the uniporter OCT2.

Authors:  Stephen H Wright; Timothy W Secomb
Journal:  Am J Physiol Renal Physiol       Date:  2022-07-21

6.  Functional significance of conserved cysteines in the human organic cation transporter 2.

Authors:  Ryan M Pelis; Yodying Dangprapai; Yaofeng Cheng; Xiaohong Zhang; Jennifer Terpstra; Stephen H Wright
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-09

Review 7.  Transport of Drugs and Endogenous Compounds Mediated by Human OCT1: Studies in Single- and Double-Transfected Cell Models.

Authors:  Bastian Haberkorn; Martin F Fromm; Jörg König
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

8.  Kinetic basis of metformin-MPP interactions with organic cation transporter OCT2.

Authors:  Philip J Sandoval; Mark Morales; Timothy W Secomb; Stephen H Wright
Journal:  Am J Physiol Renal Physiol       Date:  2019-07-17

9.  MATE1 regulates cellular uptake and sensitivity to imatinib in CML patients.

Authors:  S Harrach; C Schmidt-Lauber; T Pap; H Pavenstädt; E Schlatter; E Schmidt; W E Berdel; U Schulze; B Edemir; S Jeromin; T Haferlach; G Ciarimboli; J Bertrand
Journal:  Blood Cancer J       Date:  2016-09-16       Impact factor: 11.037

10.  Transporter-mediated drug-drug interactions with oral antidiabetic drugs.

Authors:  Sabine Klatt; Martin F Fromm; Jörg König
Journal:  Pharmaceutics       Date:  2011-10-12       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.